AstraZeneca’s campaign supporting its asthma and COPD treatment Breztri features several AI-generated elements.

The Cambridge, England-based pharmaceutical company said the recommendation, from the Committee for Medicinal Products for Human Use of the European Medicines Agency, covers Klygefa as an add-on to ...

AstraZeneca gets a Buy rating as its core business is still growing while a deep late-stage pipeline gives investors multiple ...

Pharmaceutical giant AstraZeneca is expanding its clinical trial footprint in the Philippines by tapping the Ayala Group’s health-care arm to identify and prepare ...

Bavarian Nordic has appointed Tarja Stenvall President and Chief Executive Officer, bringing in a pharmaceutical executive with more than two decades of leadership experience across Sanofi, ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Trastuzumab deruxtecan is a HER2-directed antibody drug conjugate (ADC) discovered by Daiichi Sankyo and jointly developed and commercialized by Daiichi Sankyo and AstraZeneca. The treatment combines ...

The ink was barely dry on the FDA approval letter for AstraZeneca’s Etcamah before the oral SERD suffered a key clinical ...

The HSE has said it expects to receive its full supply of flu vaccines for the forthcoming 2026-2027 national vaccination ...

Young athletes with autism were on the US Open courts with Love Serving Autism, using racquet sports to build confidence, ...

Find out what came out of the World Conference on Lung Cancer (WCLC) 2026, from late-stage successes and failures to earlier-stage promise.

GSK reported good clinical trial results with two of its lung cancer therapies – Jideytro and risvutatug rezetecan (ris-rez) ...